TaqMan MGB probe real-time fluorescence PCR detection kit for leukemia fusion genes
A fusion gene, real-time fluorescence technology, applied in DNA/RNA fragments, recombinant DNA technology, etc., can solve the problems of low specificity and sensitivity, time-consuming and labor-intensive, etc., achieve accurate detection results, reduce background signal interference, improve Effects of Differences in Tm Values
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0066] Example 1. Design and screening of primers and TaqMan-MGB probes for real-time fluorescent PCR detection of leukemia fusion genes
[0067] According to leukemia fusion genes AML1-ETO, BCR-ABL190, BCR-ABL210, CBFb-MYH11(A), CBFb-MYH11(D), CBFb-MYH11(E), E2A-PBX1, MLL-AF4, PML-RARa(bcr1 ), PML-RARa(bcr2), PML-RARa(bcr3), SIL-TAL1 and TEL-AML1 conserved regions designed primers and probes for TaqMan-MGB real-time fluorescent PCR detection, wherein 5 of the probe The 'end is fluorescently labeled with a reporter luminescent group FAM, the 3' end is labeled with a non-fluorescent quencher group NFQ, and the probe is also connected with a MGB (Minor Groove Binder) modification group. The screening principle of primers / probes is: select primers and probes with higher PCR amplification efficiency and probe binding efficiency in the target conserved region as candidate primers and probes. After screening, primers and TaqMan-MGB probes of the present invention were obtained, and...
Embodiment 2
[0110] Embodiment 2, TaqMan-MGB probe real-time fluorescent PCR detection of leukemia fusion gene
[0111] Detect 13 clinical samples with the TaqMan-MGB probe real-time fluorescence quantitative PCR detection method of the leukemia fusion gene of the present invention, the specific method comprises the following steps:
[0112] 1) Extract 13 confirmed leukemia patients (known to carry AML1-ETO, BCR-ABL190, BCR-ABL210, CBFb-MYH11(A), CBFb-MYH11(D), CBFb-MYH11(E), E2A-PBX1 , MLL-AF4, PML-RARa(bcr1), PML-RARa(bcr2), PML-RARa(bcr3), SIL-TAL1 and TEL-AML1 genes) and a peripheral blood sample from a healthy subject (control) (bone marrow or tissue is also acceptable) and 1 part of peripheral blood RNA of healthy subjects.
[0113] 2) Reverse transcribe the peripheral blood RNA of the subject extracted in step 1) into cDNA, the 20ul reverse transcription system is (all reagents are purchased from Promega): RNA 4ul (400ng), reverse transcription master mix 5.75 ul (MMLV 0.5 ul, MML...
Embodiment 3
[0117] Embodiment 3, the preparation of the TaqMan-MGB probe real-time fluorescent PCR detection kit of leukemia fusion gene
[0118] The reaction solution (premix solution) used for real-time fluorescent PCR detection of leukemia fusion gene by TaqMan-MGB probe is composed of the following components: upstream primer 1-3μL (2.5-7.5uM), downstream primer 1-3μL ( 2.5-7.5uM), 1 μL of TaqMan-MGB probe (1.25uM), 10 μL of Universal Master Mix for PCR (2×, purchased from ABI Company), and make up to 18 μL with nuclease-free water. Specifically, the test kit of the present invention includes the following components:
[0119] (1) Reverse transcription system, the components are as follows:
[0120] Reagent
company
Item No.
Volume (20ul*20)
MMLV
Promega
M1705
0.5ul*20
MMLV reaction buffer
Promega
M1705
4ul*20
RNase inhibitor
Promega
N2615
0.25ul*20
nuclease free water
QIAGEN
129112
10.25...
PUM
Property | Measurement | Unit |
---|---|---|
Sensitivity | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com